|
|
||||||||
American Journal of Clinical Nutrition, Vol 63, 709-716, Copyright © 1996 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
RK Buddington, CH Williams, SC Chen and SA Witherly
Department of Biological Sciences, Mississippi State University, Mississippi State 39762-5759, USA.
The influence of dietary fructooligosaccharide (neosugar) on the fecal flora and activities of reductive enzymes was studied in 12 healthy, adult human subjects fed a controlled diet for 42 d and given 4 g neosugar/d between days 7 and 32. Fecal samples were collected before, during, and after supplementation with neosugar to enumerate total anaerobes, aerobes, bifidobacteria, and enterobacteria, and to assay for beta-glucuronidase, nitroreductase, and glycocholic acid hydroxylase. Although the controlled diet caused an increase in total anaerobes and bifidobacteria, the highest densities occurred during supplementation with neosugar. Total aerobes and enterobacteria were less affected by diet and neosugar. Neosugar caused beta-glucuronidase and glycocholic acid hydroxylase activities to decrease 75% and 90%, respectively; both increased after supplementation with neosugar was stopped. Nitroreductase activity declined 80% after the control diet was started, but was not affected by neosugar. These findings indicate that 4 g neosugar/d alters the fecal flora in a manner perceived as beneficial by decreasing activities of some reductive enzymes.
This article has been cited by other articles:
![]() |
F. Depeint, G. Tzortzis, J. Vulevic, K. I'Anson, and G. R Gibson Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study Am. J. Clinical Nutrition, March 1, 2008; 87(3): 785 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shadid, M. Haarman, J. Knol, W. Theis, C. Beermann, D. Rjosk-Dendorfer, D. J Schendel, B. V Koletzko, and S. Krauss-Etschmann Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity a randomized, double-blind, placebo-controlled study Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1426 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Roberfroid Inulin-Type Fructans: Functional Food Ingredients J. Nutr., November 1, 2007; 137(11): 2493S - 2502S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kolida and G. R. Gibson Prebiotic Capacity of Inulin-Type Fructans J. Nutr., November 1, 2007; 137(11): 2503S - 2506S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Goh, J.-H. Lee, and R. W. Hutkins Functional Analysis of the Fructooligosaccharide Utilization Operon in Lactobacillus paracasei 1195 Appl. Envir. Microbiol., September 15, 2007; 73(18): 5716 - 5724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roberfroid Prebiotics: The Concept Revisited J. Nutr., March 1, 2007; 137(3): 830S - 837S. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. De Preter, T. Vanhoutte, G. Huys, J. Swings, L. De Vuyst, P. Rutgeerts, and K. Verbeke Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G358 - G368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sonoyama, H. Watanabe, J. Watanabe, N. Yamaguchi, A. Yamashita, H. Hashimoto, E. Kishino, K. Fujita, M. Okada, S. Mori, et al. Allergic Airway Eosinophilia Is Suppressed in Ovalbumin-Sensitized Brown Norway Rats Fed Raffinose and {alpha}-Linked Galactooligosaccharide J. Nutr., March 1, 2005; 135(3): 538 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bouhnik, L. Raskine, G. Simoneau, E. Vicaut, C. Neut, B. Flourie, F. Brouns, and F. R Bornet The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1658 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kimura, Y. Nagata, and R. K. Buddington Some Dietary Fibers Increase Elimination of Orally Administered Polychlorinated Biphenyls but Not That of Retinol in Mice J. Nutr., January 1, 2004; 134(1): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Duggan, M. E Penny, P. Hibberd, A. Gil, A. Huapaya, A. Cooper, F. Coletta, C. Emenhiser, and R. E Kleinman Oligofructose-supplemented infant cereal: 2 randomized, blinded, community-based trials in Peruvian infants Am. J. Clinical Nutrition, April 1, 2003; 77(4): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Buddington, J. B. Donahoo, and R. K. Buddington Dietary Oligofructose and Inulin Protect Mice from Enteric and Systemic Pathogens and Tumor Inducers J. Nutr., March 1, 2002; 132(3): 472 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kimura, Y. Nagata, C. W. Bryant, and R. K. Buddington Nondigestible Oligosaccharides Do Not Increase Accumulation of Lipid Soluble Environmental Contaminants by Mice J. Nutr., January 1, 2002; 132(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H Cummings, G. T Macfarlane, and H. N Englyst Prebiotic digestion and fermentation Am. J. Clinical Nutrition, February 1, 2001; 73(2): 415S - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hughes and I.R. Rowland Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon Carcinogenesis, January 1, 2001; 22(1): 43 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Luo, M. Van Yperselle, S. W. Rizkalla, F. Rossi, F. R. J. Bornet, and G. Slama Chronic Consumption of Short-Chain Fructooligosaccharides Does Not Affect Basal Hepatic Glucose Production or Insulin Resistance in Type 2 Diabetics J. Nutr., June 1, 2000; 130(6): 1572 - 1577. [Abstract] [Full Text] |
||||
![]() |
J. L. Slavin Mechanisms for the Impact of Whole Grain Foods on Cancer Risk J. Am. Coll. Nutr., June 1, 2000; 19(90003): 300S - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Menne and N. Guggenbuhl Fn-type Chicory Inulin Hydrolysate Has a Prebiotic Effect in Humans J. Nutr., May 1, 2000; 130(5): 1197 - 1199. [Abstract] [Full Text] |
||||
![]() |
G. R. Gibson and R. Fuller Aspects of In Vitro and In Vivo Research Approaches Directed Toward Identifying Probiotics and Prebiotics for Human Use J. Nutr., February 1, 2000; 130(2): 391 - 391. [Abstract] [Full Text] |
||||
![]() |
J. L Slavin, M. C Martini, D. R Jacobs Jr, and L. Marquart Plausible mechanisms for the protectiveness of whole grains Am. J. Clinical Nutrition, September 1, 1999; 70(3): 459S - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Gibson Dietary Modulation of the Human Gut Microflora Using the Prebiotics Oligofructose and Inulin J. Nutr., July 1, 1999; 129(7): 1438 - 1438. [Abstract] [Full Text] |
||||
![]() |
R. K. Buddington and E. Weiher The Application of Ecological Principles and Fermentable Fibers to Manage the Gastrointestinal Tract Ecosystem J. Nutr., July 1, 1999; 129(7): 1446 - 1446. [Abstract] [Full Text] |
||||
![]() |
M. S Alles, R. Hartemink, S. Meyboom, J. L Harryvan, K. M. Van Laere, F. M Nagengast, and J. G. Hautvast Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer Am. J. Clinical Nutrition, May 1, 1999; 69(5): 980 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D. Collins and G. R Gibson Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut Am. J. Clinical Nutrition, May 1, 1999; 69 (5): 1052S - 1057S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T Macfarlane and J. H Cummings Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ, April 10, 1999; 318(7189): 999 - 1003. [Full Text] |
||||
![]() |
Y. Bouhnik, K. Vahedi, L. Achour, A. Attar, J. Salfati, P. Pochart, P. Marteau, B. Flourie, F. Bornet, and J.-C. Rambaud Short-Chain Fructo-Oligosaccharide Administration Dose-Dependently Increases Fecal Bifidobacteria in Healthy Humans J. Nutr., January 1, 1999; 129(1): 113 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Amann, M. J. Kullen, M. C. Martini, F. F. Busta, and L. J. Brady Consumption of Exogenous Bifidobacteria Does Not Alter Fecal Bifidobacteria and Breath Hydrogen Excretion in Humans J. Nutr., June 1, 1998; 128(6): 996 - 1002. [Abstract] [Full Text] |
||||
![]() |
M. B. Roberfroid, J. A. E. Van Loo, and G. R. Gibson The Bifidogenic Nature of Chicory Inulin and Its Hydrolysis Products J. Nutr., January 1, 1998; 128(1): 11 - 19. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |